---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-001026"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2022-01-05T23:59:59+00:00"
generated_at: "2026-06-27T20:27:40.468123+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eloxx receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until July 5, 2022

## Summary
- Closing bid price of common stock below $1.00 for 30 consecutive business days as of Jan 3, 2022.
- Company has until July 5, 2022 to regain compliance; may qualify for an additional 180-day grace period.
- Options to cure include a reverse stock split; no assurance of regaining compliance.
- Stock continues trading on Nasdaq Global Market under symbol ELOX during the cure period.

## SEC filing metadata
- accession: 0001104659-22-001026
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2022-01-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/0001104659-22-001026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/tm221588d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-001026
- JSON: https://secwatch.observer/filing/0001104659-22-001026.json
- Plain text: https://secwatch.observer/filing/0001104659-22-001026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.